HEPLISAV-B

The number of biotech stocks posting gains outstripped those recording losses for the week. Notable among the gainers for the week were Odonate Therapeutics Inc (NASDAQ: ODT) — which reported its financial results Feb. 14 and has been rallying ever since — and ARMO Biosciences Inc...

October turned out to be a month of plenty for biotech investors, with several potential treatment candidates knocking at the FDA altar. The make-or-break FDA review event usually creates volatility in the space, offering an excellent opportunity for traders to make profits. The iShares NASDAQ...

Nasdaq halted Dynavax Technologies Corporation (NASDAQ: DVAX) trading for the entirety of Friday’s session -- both before and after an announcement of regulatory progress for the company’s Hepatitis B vaccine, HEPLISAV-B. Shortly after 3p.m. ET, it was announced that The Vaccines and...